Back to today’s briefing

Story perspectives

HIV Vaccine Research Halted Amid Trump Administration Cuts

6/12/2025

49 9

Summary

Story summary

The Trump administration's drastic cuts to HIV vaccine research have put crucial projects on pause, including a $258 million NIH initiative and trials in Africa. Researchers are alarmed by the dwindling funds, jeopardizing the fight for an effective vaccine. Compounding the issue, Gilead's clinical hold on two HIV treatment candidates raises further concerns about safety and progress.

1 of 1

Story summary

The Trump administration's drastic cuts to HIV vaccine research have put crucial projects on pause, including a $258 million NIH initiative and trials in Africa. Researchers are alarmed by the dwindling funds, jeopardizing the fight for an effective vaccine. Compounding the issue, Gilead's clinical hold on two HIV treatment candidates raises further concerns about safety and progress.